# Judy E. Garber

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/judy-e-garber/

## Facts

| Field | Value |
| --- | --- |
| Citations | 68,345 |
| Field | BRCA gene mutations in cancer |
| h-index | 130 |
| i10-index | 413 |
| Last Known Institution | Dana-Farber Cancer Institute |
| OpenAlex ID | https://openalex.org/A5005206482 |
| ORCID iD | https://orcid.org/0000-0001-9449-3982 |
| Works | 975 |

## Researcher papers

Showing 12 of 14.

- [Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer](https://scholariq.org/papers/adjuvant-olaparib-for-patients-with-i-brca1-i-or-i-brca2-i-mutated-breast-cancer/)
- [De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017](https://scholariq.org/papers/de-escalating-and-escalating-treatments-for-early-stage-breast-cancer-the-st/)
- [NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017](https://scholariq.org/papers/nccn-guidelines-insights-genetic-familial-high-risk-assessment-breast-and/)
- [Genetic/Familial High-Risk Assessment: Breast and Ovarian](https://scholariq.org/papers/genetic-familial-high-risk-assessment-breast-and-ovarian/)
- [Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses](https://scholariq.org/papers/genome-wide-association-study-identifies-32-novel-breast-cancer-susceptibility/)
- [Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine](https://scholariq.org/papers/whole-exome-sequencing-and-clinical-interpretation-of-formalin-fixed-paraffin/)
- [Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome](https://scholariq.org/papers/cancer-screening-recommendations-for-individuals-with-li-fraumeni-syndrome/)
- [Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/breast-cancer-screening-and-diagnosis-version-3-2018-nccn-clinical-practice/)
- [NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-genetic-familial-high-risk-assessment-breast-ovarian/)
- [Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer](https://scholariq.org/papers/association-of-type-and-location-of-i-brca1-i-and-i-brca2-i-mutations-with-risk/)
- [BRCAPRO Validation, Sensitivity of Genetic Testing of <i>BRCA1/BRCA2</i>, and Prevalence of Other Breast Cancer Susceptibility Genes](https://scholariq.org/papers/brcapro-validation-sensitivity-of-genetic-testing-of-i-brca1-brca2-i-and/)
- [Breast Cancer Screening and Diagnosis](https://scholariq.org/papers/breast-cancer-screening-and-diagnosis/)

## Researcher topics

- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)

## Researcher university

- [Dana-Farber Cancer Institute](https://scholariq.org/institutions/dana-farber-cancer-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.